Eleni Karantali1, Dimitrios Kazis2, Jack McKenna3, Symela Chatzikonstantinou2, Fivos Petridis2, Ioannis Mavroudis3. 1. Third Neurological Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. lena.kar@outlook.com. 2. Third Neurological Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. 3. Department of Neurosciences, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Abstract
PURPOSE: Traumatic brain injury is one of the leading causes of disability worldwide. Mild traumatic brain injury (TBI) is the most common and benign form of TBI, usually referred to by the medical term "concussion". The purpose of our systematic review and meta-analysis was to explore the role of serum and CSF neurofilament light chain (NfL) as a potential biomarker in concussion. METHODS: We systematically searched PubMed, Web of Science, and Cochrane databases using specific keywords. As the primary outcome, we assessed CSF or serum NfL levels in patients with concussion and head impacts versus controls. The role of NfL in patients with concussion and head impacts compared to healthy controls was also assessed, as well as in sports-related and military-related conditions. RESULTS: From the initial 617 identified studies, we included 24 studies in our qualitative analysis and 14 studies in our meta-analysis. We found a statistically significant increase of serum NfL in patients suffering from a concussion or head impacts compared to controls (p = 0.0023), highlighting its potential role as a biomarker. From our sub-group analyses, sports-related concussion and mild TBI were mostly correlated with increased serum NfL values. Compared to controls, sports-related concussion was significantly associated with higher NfL levels (p = 0.0015), while no association was noted in patients suffering from head impacts or military-related TBI. CONCLUSION: Serum NfL levels are higher in all patients suffering from concussion compared to healthy controls. The sports-related concussion was specifically associated with higher levels of NfL. Further studies exploring the use of NfL as a diagnostic and prognostic biomarker in mild TBI and head impacts are needed.
PURPOSE: Traumatic brain injury is one of the leading causes of disability worldwide. Mild traumatic brain injury (TBI) is the most common and benign form of TBI, usually referred to by the medical term "concussion". The purpose of our systematic review and meta-analysis was to explore the role of serum and CSF neurofilament light chain (NfL) as a potential biomarker in concussion. METHODS: We systematically searched PubMed, Web of Science, and Cochrane databases using specific keywords. As the primary outcome, we assessed CSF or serum NfL levels in patients with concussion and head impacts versus controls. The role of NfL in patients with concussion and head impacts compared to healthy controls was also assessed, as well as in sports-related and military-related conditions. RESULTS: From the initial 617 identified studies, we included 24 studies in our qualitative analysis and 14 studies in our meta-analysis. We found a statistically significant increase of serum NfL in patients suffering from a concussion or head impacts compared to controls (p = 0.0023), highlighting its potential role as a biomarker. From our sub-group analyses, sports-related concussion and mild TBI were mostly correlated with increased serum NfL values. Compared to controls, sports-related concussion was significantly associated with higher NfL levels (p = 0.0015), while no association was noted in patients suffering from head impacts or military-related TBI. CONCLUSION: Serum NfL levels are higher in all patients suffering from concussion compared to healthy controls. The sports-related concussion was specifically associated with higher levels of NfL. Further studies exploring the use of NfL as a diagnostic and prognostic biomarker in mild TBI and head impacts are needed.
Authors: Lorenzo Gaetani; Kaj Blennow; Paolo Calabresi; Massimiliano Di Filippo; Lucilla Parnetti; Henrik Zetterberg Journal: J Neurol Neurosurg Psychiatry Date: 2019-04-09 Impact factor: 10.154
Authors: Kimberly G Harmon; James R Clugston; Katherine Dec; Brian Hainline; Stanley A Herring; Shawn Kane; Anthony P Kontos; John J Leddy; Michael A McCrea; Sourav K Poddar; Margot Putukian; Julie C Wilson; William O Roberts Journal: Clin J Sport Med Date: 2019-03 Impact factor: 3.638
Authors: Lynda Mainwaring; Kaleigh M Ferdinand Pennock; Sandhya Mylabathula; Benjamin Z Alavie Journal: Int J Psychophysiol Date: 2018-02-03 Impact factor: 2.997
Authors: Michael Khalil; Charlotte E Teunissen; Markus Otto; Fredrik Piehl; Maria Pia Sormani; Thomas Gattringer; Christian Barro; Ludwig Kappos; Manuel Comabella; Franz Fazekas; Axel Petzold; Kaj Blennow; Henrik Zetterberg; Jens Kuhle Journal: Nat Rev Neurol Date: 2018-10 Impact factor: 42.937
Authors: M Balestreri; M Czosnyka; D A Chatfield; L A Steiner; E A Schmidt; P Smielewski; B Matta; J D Pickard Journal: J Neurol Neurosurg Psychiatry Date: 2004-01 Impact factor: 10.154
Authors: John G Hanly; Alexandra Legge; Lyna Kamintsky; Alon Friedman; Javeria A Hashmi; Steven D Beyea; John Fisk; Antonina Omisade; Cynthia Calkin; Tim Bardouille; Chris Bowen; Kara Matheson; Marvin J Fritzler Journal: Lupus Sci Med Date: 2022-06